{
    "title": "Electrolyzed Physiological Saline vs Cancer - Chlorozone",
    "inventor_name": "Merton Gwyynn Ross",
    "publication_year": null,
    "device_name": "Chlorozone (electrolyzed physiological saline)",
    "goal": "To treat cancer by delivering an oxidizing solution (chlorine equivalent) that reverses cellular hypoxia and normalizes DNA replication.",
    "problem_addressed": "Cancerous tumors and associated hypoxia-induced cellular damage.",
    "concept_summary": "The invention describes the preparation of physiological saline that has been electrolyzed to generate a solution containing approximately 65 ppm of active oxidants-primarily hypochlorite, with smaller amounts of ozone and free radicals-collectively termed \"chlorine equivalent\". When administered intravenously or intramuscularly, the solution is claimed to act as a supplemental oxidant, alleviating cellular hypoxia, correcting chemical imbalances, and thereby causing rapid regression of malignant tissue.",
    "detailed_description": "The method involves passing an electric current (3.5-7 V) through a sodium-chloride brine (physiological saline) to produce hypochlorite, ozone, and free radicals. The resulting solution is injected directly into or around tumors, or administered systemically via IV infusion. Reported clinical observations include tumor shrinkage within 48-72 hours, remission of advanced cancers, and extended survival in case patients. The author attributes the therapeutic effect to oxidation-mediated reversal of hypoxia and restoration of normal DNA replication processes.",
    "category": "Medical & Dental Technologies",
    "principles": [
        "Oxidative therapy",
        "Hypoxia reversal",
        "Bioelectrolysis",
        "Chlorine-based oxidants"
    ],
    "scientific_domains": [
        "Medicine",
        "Oncology",
        "Biochemistry",
        "Electrochemistry"
    ],
    "mechanisms_of_action": [
        "Oxidation of cellular components",
        "Mitigation of cellular hypoxia",
        "Normalization of DNA replication"
    ],
    "materials": [
        "Physiological saline",
        "Sodium chloride",
        "Hypochlorite",
        "Ozone",
        "Free radicals"
    ],
    "energy_sources": [
        "Electricity"
    ],
    "inputs": [
        "Physiological saline",
        "Electric current",
        "Sodium chloride"
    ],
    "outputs": [
        "Chlorine-equivalent solution (hypochlorite, ozone, free radicals)",
        "Chlorozone injection"
    ],
    "claimed_performance": "Rapid tumor regression (48-72 h), disappearance of isolated tumors, restoration of normal tissue, and survival extension up to 71/2 months in advanced cancer patients.",
    "experimental_evidence": "Multiple case histories are described: (1) a patient with extensive upper-body malignancy showed tumor retreat after local IM injections and disappearance of isolated tumors within 48 h; (2) a comparative anecdote where a treated patient survived 71/2 months versus an untreated control who died within a week; (3) early-stage lip cancer resolved after three IV injections (750 cc) over two weeks, with no tumor detectable after one month.",
    "replication_status": "No controlled or replicated studies are reported; evidence consists of anecdotal case histories.",
    "keywords": [
        "Chlorozone",
        "Electrolyzed saline",
        "Hypoxia",
        "Oxidant therapy",
        "Cancer remission",
        "Bioelectrolysis"
    ],
    "related_technologies": [
        "Electrolyzed water therapy",
        "Ozone therapy",
        "Chlorine dioxide disinfection",
        "Bioelectrolysis devices"
    ],
    "controversy_level": "high",
    "confidence_score": 0.6,
    "practicability_score": 0.5,
    "fringe_score": 0.8,
    "evidence_strength": 0.4,
    "risk_score": 0.6,
    "trl_estimate": 3,
    "source_urls": [
        "https://rexresearch.com",
        "https://patents.google.com/patent/US3616355"
    ],
    "organizations": [
        "RexResearch",
        "United States Patent Office"
    ],
    "applications": [
        "Cancer therapy",
        "Wound healing",
        "Antimicrobial disinfection"
    ],
    "limitations": [
        "Lack of controlled clinical trials",
        "Potential toxicity of chlorine/ozone at high doses",
        "Unclear optimal dosing and administration protocol"
    ],
    "open_questions": [
        "Exact biochemical pathways by which the oxidant solution reverses hypoxia",
        "Long-term safety and side-effect profile",
        "Standardized dosage and delivery methods"
    ],
    "red_flags": [
        "Claims are based on anecdotal case reports rather than peer-reviewed studies",
        "No regulatory approval for medical use",
        "Potential for misuse or over-dosage of oxidizing agents"
    ],
    "evidence_quotes": [
        "When enough of his electrolyzed physiological saline can be introduced to a cancer site the replication of cancerous tissue can revert to the replication of normal tissue in a period of about 72 hours.",
        "Injections into and around several isolated tumors caused these to disappear within about 48 hours -- and there was no sign of their recurrence during the patient's remaining lifetime.",
        "Patient A responded very well to Chlorozone injections, was able to resume a moderately active life, and lived on, relatively free of pain for 7-1/2 months.",
        "After three IV injections of Chlorozone totaling 750 cc over a two week period, the lip had returned to normal size and color, and reexamination ... showed no signs of a tumor."
    ]
}